Cannabis as a Complementary Treatment in Multiple Sclerosis

Clinical trial NCT05092191 · RECRUITING

Trial details

NCT number: NCT05092191
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2022-11-10
Primary completion: 2025-04-10
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.